Natrixam (Indapamide, Amlodipine Besilate)

Indapamide acts as a thiazide‑like diuretic, inhibiting sodium reabsorption in the distal tubule, which reduces plasma volume. Amlodipine blocks L‑type calcium channels in vascular smooth muscle, causing arterial vasodilation. The two mechanisms complement each other, providing greater blood‑pressure reduction than either agent alone.

The appropriate dose of Natrixam is determined by the prescribing healthcare professional based on the individual’s blood‑pressure profile, renal function, and concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for Natrixam in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To order Natrixam, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Natrixam offers the convenience of a single tablet with a fixed ratio of indapamide and amlodipine, which can improve adherence compared with taking two separate pills. Pharmacologically the effect is equivalent, but the combination reduces pill burden and simplifies dosing schedules.

Natrixam tablets should be stored at room temperature, below 25 °C, in the original blister pack or container. Keep the product away from moisture, direct sunlight, and excessive heat to maintain stability and potency.

Natrixam is taken orally, usually once daily, with or without food, as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically advised by a healthcare professional.

Serious risks include severe hypotension, electrolyte imbalances (especially low potassium or sodium), acute renal impairment, angioedema, and rare hepatic dysfunction. Patients should be educated to seek immediate medical attention if they experience symptoms such as fainting, swelling of the face or throat, or sudden loss of kidney function.

Natrixam is contraindicated in patients with known hypersensitivity to indapamide, amlodipine, or any excipients in the tablet. It should also be avoided in individuals with severe renal or hepatic impairment, uncontrolled heart failure, or in those taking certain medications that may cause dangerous interactions, unless closely monitored by a physician.